1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

‘Important Steps To Ensure Equitable Care’: Medtronic Exec On Pulse Ox Panel

 
• By Elizabeth Orr

Sam Ajizian, chief medical officer of Medtronic’s patient monitoring operating unit, spoke to Medtech Insight about his reaction to a recent FDA panel meeting on ways to improve pulse oximetry accuracy and equity.

Caregiver securing pulse oximeter on the hand of a Black patient.
• Source: Shutterstock

A plan put forward by the US Food and Drug Administration and supported by most participants in a 2 February meeting of the agency’s anesthesiology and respiratory therapy devices advisory panel would more than double the minimum sample size needed in pulse oximeter clinical trials, as well as increasing the need for representation of people with darker skin tones. The move could be an important step for health equity, but what will it mean for device manufacturers?

Sam Ajizian, chief medical officer of Medtronic’s patient monitoring operating unit, spoke to Medtech Insight about his reaction to the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By Sue Sutter

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 
• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.